Mayo, Baby Boy .
HRN: 23-66-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/17/2023
09/23/2023
IV
30mg
OD
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes